{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:46:56Z","timestamp":1763765216656},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1006\/gyno.1999.5564","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"248-253","source":"Crossref","is-referenced-by-count":37,"title":["Matrix Metalloproteinases and Their Inhibitors in Gestational Trophoblastic Diseases and Normal Placenta"],"prefix":"10.1006","volume":"75","author":[{"given":"Gyorgy L.","family":"Vegh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Selcuk Tuncer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilmos","family":"Fulop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Genest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel C.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1999.5564_RF1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/cncr.2820710430","article-title":"Diagnosis and management of gestational trophoblastic disease","volume":"71","author":"Lewis","year":"1993","journal-title":"Cancer"},{"key":"10.1006\/gyno.1999.5564_RF2","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199612053352306","article-title":"Chorionic tumors","volume":"335","author":"Berkowitz","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.1999.5564_RF3","series-title":"Gynecologic Oncology","first-page":"328","article-title":"The Management of Molar Pregnancy and Gestational Trophoblastic Tumors","author":"Berkowitz","year":"1993"},{"key":"10.1006\/gyno.1999.5564_RF4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/excr.1996.0273","article-title":"Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A","volume":"227","author":"Crescimanno","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1006\/gyno.1999.5564_RF5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00049525","article-title":"Mechanism of trophoblast invasiveness and their control: the role of proteases and protease inhibitors","volume":"9","author":"Lala","year":"1994","journal-title":"Cancer Metast Rev"},{"key":"10.1006\/gyno.1999.5564_RF6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s004410050987","article-title":"Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta","volume":"291","author":"Huppertz","year":"1998","journal-title":"Cell Tissue Res"},{"key":"10.1006\/gyno.1999.5564_RF7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.humrep.a136024","article-title":"Gelatinase and oncofetal fibronectin expression is dependent on integrin expression on human cytotrophoblasts","volume":"10","author":"Bishof","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1006\/gyno.1999.5564_RF8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00414172","article-title":"Immunohistochemical localization of serine-protease inhibitors in the human placenta","volume":"278","author":"Castellucci","year":"1994","journal-title":"Cell Tissue Res"},{"key":"10.1006\/gyno.1999.5564_RF9","series-title":"Ovarian Cancer 5","first-page":"121","article-title":"Tumour Cell\u2013Stromal Cell Interactions: Proteases and Protease Inhibitors","author":"Leber","year":"1998"},{"key":"10.1006\/gyno.1999.5564_RF10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/370061a0","article-title":"A matrix metalloproteinase expressed on the surface of invasive tumor cells","volume":"370","author":"Sato","year":"1994","journal-title":"Nature"},{"key":"10.1006\/gyno.1999.5564_RF11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/gut.43.6.791","article-title":"Matrix metalloproteinases and their inhibitors in gastric cancer","volume":"43","author":"Murray","year":"1998","journal-title":"Gut"},{"key":"10.1006\/gyno.1999.5564_RF12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0163-7258(93)90074-N","article-title":"Tissue inhibitor of metalloproteinases (TIMP, akaEPA): structure, control of expression and biological functions","volume":"59","author":"Denhardt","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1006\/gyno.1999.5564_RF13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/bies.950140705","article-title":"The matrix-degrading metalloproteinases","volume":"14","author":"Matrisian","year":"1992","journal-title":"Bioessays"},{"key":"10.1006\/gyno.1999.5564_RF14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"JNCI"},{"key":"10.1006\/gyno.1999.5564_RF15","series-title":"Gestational Trophoblastic Disease","first-page":"127","article-title":"Presentation and Management of Molar Pregnancy","author":"Berkowitz","year":"1997"},{"key":"10.1006\/gyno.1999.5564_RF16","first-page":"37","article-title":"Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy","volume":"43","author":"Goldstein","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1006\/gyno.1999.5564_RF17","first-page":"101","article-title":"c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma","volume":"43","author":"Fulop","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1006\/gyno.1999.5564_RF18","first-page":"861","article-title":"Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis","volume":"2","author":"Cottam","year":"1993","journal-title":"Intl J Oncol"},{"key":"10.1006\/gyno.1999.5564_RF19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ijc.2910440434","article-title":"Metalloproteinases and cancer invasion and metastasis","volume":"44","author":"Murphy","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.1999.5564_RF20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm0496-461","article-title":"Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer","volume":"2","author":"Murray","year":"1996","journal-title":"Nat Med"},{"key":"10.1006\/gyno.1999.5564_RF21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A","article-title":"Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer","volume":"185","author":"Murray","year":"1998","journal-title":"J Pathol"},{"key":"10.1006\/gyno.1999.5564_RF22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0344-0338(11)80659-X","article-title":"Location of 72-kD metalloproteinase (type IV collagenase) in untreated prostatic adenocarcinoma","volume":"191","author":"Montironi","year":"1995","journal-title":"Path Res Pract"},{"key":"10.1006\/gyno.1999.5564_RF23","first-page":"2057","article-title":"Immunohistochemical evaluation of type IV collagenase (72-kD metalloproteinase) in prostatic intraepithelial neoplasia","volume":"16","author":"Montironi","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1006\/gyno.1999.5564_RF24","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/1097-0142(19951215)76:12<2565::AID-CNCR2820761224>3.0.CO;2-B","article-title":"Characterization of extracellular matrix degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form","volume":"76","author":"Tamakoshi","year":"1995","journal-title":"Cancer"},{"key":"10.1006\/gyno.1999.5564_RF25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004347-199810000-00002","article-title":"Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix","volume":"17","author":"Davidson","year":"1998","journal-title":"Int J Gynecol Pathol"},{"key":"10.1006\/gyno.1999.5564_RF26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/gyno.1998.5157","article-title":"Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation","volume":"72","author":"Talvensaari-Mattila","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5564_RF27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/gyno.1998.5285","article-title":"Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix\u2014clinicopathologic study using immunohistochemistry and mRNA in situ hybridization","volume":"72","author":"Davidson","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5564_RF28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0163-7258(97)00023-5","article-title":"Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with specifial focus on batimastat and marimastat","volume":"75","author":"Rasmussen","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1006\/gyno.1999.5564_RF29","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.1998.16.6.2150","article-title":"Phase I trial Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer","volume":"16","author":"Wojtowitz-Praga","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899955646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899955646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T15:25:24Z","timestamp":1557329124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825899955646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["S0090825899955646"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1999.5564","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}